<?xml version="1.0" encoding="UTF-8"?>
<p class="p">
 <italic class="italic">d</italic>-Limonene has been shown to possess antioxidant, anti-inflammatory [
 <xref rid="B12-ijms-19-01966" ref-type="bibr" class="xref">12</xref>], and anticarcinogenic [
 <xref rid="B8-ijms-19-01966" ref-type="bibr" class="xref">8</xref>] effects. It is not acutely toxic, nephrotoxic, or carcinogenic, but the oxidized 
 <italic class="italic">d</italic>-limonene may carry some toxicity. Unoxidized 
 <italic class="italic">d</italic>-limonene is listed as an allergen by the EU, and moderately allergenic in Germany [
 <xref rid="B8-ijms-19-01966" ref-type="bibr" class="xref">8</xref>]. Unoxidized 
 <italic class="italic">d</italic>-limonene was allergenic in 0.2% of dermatitis patients when tested at 2–3% [
 <xref rid="B8-ijms-19-01966" ref-type="bibr" class="xref">8</xref>]. No positive skin reactions were observed when testing the 98% pure 
 <italic class="italic">d</italic>-limonene at 20% in dermatitis patients [
 <xref rid="B175-ijms-19-01966" ref-type="bibr" class="xref">175</xref>]. Undiluted 
 <italic class="italic">d</italic>-limonene was moderately irritating to rabbits [
 <xref rid="B167-ijms-19-01966" ref-type="bibr" class="xref">167</xref>]. 
 <italic class="italic">d</italic>-Limonene was irritating at concentrations of 70–80%, a weak irritant at 50%, and a non-irritant at concentrations of 20–30%. The acute dermal LD
 <sub class="sub">50</sub> of 
 <italic class="italic">d</italic>-limonene was &gt;5 g/kg in rabbits, while the acute oral LD
 <sub class="sub">50</sub> was &gt;5 g/kg in rats [
 <xref rid="B167-ijms-19-01966" ref-type="bibr" class="xref">167</xref>].
</p>
